Aligos Therapeutics, Inc. (ALGS)
5.84
+0.08
(+1.39%)
USD |
NASDAQ |
May 26, 13:51
Aligos Therapeutics EPS Diluted (Quarterly) : -2.215 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.04M |
| Revenue (Quarterly) | 2.83M |
| Total Expenses (Quarterly) | 25.87M |
| Enterprise Value | -15.09M |
| Gross Profit Margin (Quarterly) | 87.77% |
| Profit Margin (Quarterly) | -814.1% |
| Earnings Yield | -149.0% |
| Normalized Earnings Yield | -151.43 |